Chemours
472 hedge funds and large institutions have $3.23B invested in Chemours in 2022 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 101 increasing their positions, 188 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
16% less call options, than puts
Call options by funds: $63.2M | Put options by funds: $75.4M
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
46% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 188
Holders
472
Holding in Top 10
5
Calls
$63.2M
Puts
$75.4M
Top Buyers
| 1 | +$61.6M | |
| 2 | +$36M | |
| 3 | +$23.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$17M |
Top Sellers
| 1 | -$33.6M | |
| 2 | -$25.8M | |
| 3 | -$23.7M | |
| 4 |
AWAM
Appian Way Asset Management
New York
|
-$19M |
| 5 |
Amundi
Paris,
France
|
-$18.1M |